Streptococcus pneumoniae is a highly important respiratory pathogen that causes infections in children, elderly people and immunocompromised people around the world. Pneumococcal vaccines licensed did not reach to eradicate the pneumococcal infection. In a previous study was demonstrated the effectiveness of a nasal experimental vaccine that consisted in a pneumococcal protective protein A (PppA) co-administrated with heat-killed-Lactobacillus casei (LcM), in mice model of respiratory pneumococcal challenge. In the present work the safety of the experimental vaccine LcM + PppA and its components were evaluated through hematological, biochemical and immune parameters in a model infection with S. pneumoniae. Thus, alanine transaminase activit...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
Background: At present, available pneumococcal vaccines have failed to eradicate infections caused b...
Strategies for the development of new vaccines against Streptococcus pneumoniae infections try to ov...
Strategies for the development of new vaccines against Streptococcus pneumoniae infections try to ov...
Background - Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are n...
Background - Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are n...
Background - Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are n...
Nisin-controlled gene expression was used to develop a recombinant strain of Lactococcus lactis that...
In the present work, we evaluated if oral immunization with the pneumococcal protective protein A (P...
In this work we assessed the immune response induced by combinations of live (LcV) and heat-killed (...
Lactococcus lactis NZ9000 is a non-pathogenic non-invasive bacterium extensively used for the delive...
Background/Purpose: Oral immunization with Lactococcus lactis PppA (LPA+), a recombinant strain that...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
Background: At present, available pneumococcal vaccines have failed to eradicate infections caused b...
Strategies for the development of new vaccines against Streptococcus pneumoniae infections try to ov...
Strategies for the development of new vaccines against Streptococcus pneumoniae infections try to ov...
Background - Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are n...
Background - Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are n...
Background - Economical and effective vaccines against Streptococcus pneumoniae (pneumococcus) are n...
Nisin-controlled gene expression was used to develop a recombinant strain of Lactococcus lactis that...
In the present work, we evaluated if oral immunization with the pneumococcal protective protein A (P...
In this work we assessed the immune response induced by combinations of live (LcV) and heat-killed (...
Lactococcus lactis NZ9000 is a non-pathogenic non-invasive bacterium extensively used for the delive...
Background/Purpose: Oral immunization with Lactococcus lactis PppA (LPA+), a recombinant strain that...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...
We report the development of a novel protein-based nasal vaccine against Streptococcus pneumoniae, i...